AEterna Zentaris Inc. (AEZS)

[chmcnfunds]

They have suspended the Phase 2 study of this. So the results must not have been that spectacular. Maybe good drug, but not proven useful to AEZS:

_____________________________________________________

Doxorubicin-GnRH Agonist Conjugate AEZS-108 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
This study has suspended participant recruitment.
(Drug shortage)
Sponsor:
University of Southern California
Collaborators:
National Cancer Institute (NCI)
AEterna Zentaris
Information provided by (Responsible Party):
University of Southern California
ClinicalTrials.gov Identifier:
NCT01240629
First received: June 30, 2010
Last updated: May 21, 2015
Last verified: May 2015
History of Changes

https://clinicaltrials.gov/ct2/show/NCT01240629?term=AEZS&rank=4

_______________________________________________

AEZS